Afonso A, Schmiedl S, Becker C, Tcherny-Lessenot S, Primatesta P, Plana E, Souverein P, Wang Y, Korevaar JC, Hasford J, Reynolds R, de Groot MC, Schlienger R, Klungel O, Rottenkolber M. A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. 2016 Sep;72(9):1105-16.
Ara R, Basarir H, Ward SE. Principles of health economic evaluations of lipid-lowering strategies. Curr Opin Lipidology. 2012 Aug;23(4):271-81. doi: 10.1097/MOL.0b013e32835423d9
Adams MR, Golden DL, Anthony MS, Williams JK. Inhibitory effects of soy protein isolate on atherosclerosis in mice do not require the presence of LDL receptors or effects on plasma lipoproteins. J Nutr. 2002;132:602S.
Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. J Nutr. 2000 Mar;130(3):662S-3S.
Anthony MS, Clarkson TB, Hughes CLJr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr. 1996 Jan;126(1):43-50.
Anthony MS, Clarkson TB, Weddle DL, Wolfe MS. Effects of soy protein phytoestrogens on cardiovascular risk. J Nutr. 1995 Mar;125(Suppl 3):803S-4S.